SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-002100
Filing Date
2019-02-14
Accepted
2019-02-14 16:45:45
Documents
58
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 789333
2 ex31-1.htm EX-31.1 19622
3 ex32-1.htm EX-32.1 7565
  Complete submission text file 0001493152-19-002100.txt   3139310

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE vbio-20181231.xml EX-101.INS 463170
5 XBRL SCHEMA FILE vbio-20181231.xsd EX-101.SCH 38598
6 XBRL CALCULATION FILE vbio-20181231_cal.xml EX-101.CAL 44054
7 XBRL DEFINITION FILE vbio-20181231_def.xml EX-101.DEF 111020
8 XBRL LABEL FILE vbio-20181231_lab.xml EX-101.LAB 268767
9 XBRL PRESENTATION FILE vbio-20181231_pre.xml EX-101.PRE 198232
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53832 | Film No.: 19607585
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9